Search Results - "Alharbi, Metab"

Refine Results
  1. 1
  2. 2
  3. 3

    An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy by Naveed, Muhammad, Batool, Zainab, Aziz, Tariq, Javed, Khushbakht, Ali, Nouman, Rehman, Hafiz Muzzammel, Alharbi, Metab, Alasmari, Abdullah F, Alshammari, Abdulrahman

    Published in Scientific reports (02-11-2024)
    “…Breast cancer remains a major health threat throughout the world specifically in women above 30 years of age however, it is rarely known to affect men as well…”
    Get full text
    Journal Article
  4. 4

    Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design by Naveed, Muhammad, Javed, Khushbakht, Aziz, Tariq, Abid, Amina, Rehman, Hafiz Muzzammel, Alharbi, Metab, Alshammari, Abdulrahman, Alasmari, Abdullah F.

    Published in Scientific reports (28-07-2024)
    “…Hepatocellular carcinoma (HCC) incidence varies widely around the world and is impacted by factors such as the prevalence of chronic hepatitis B and C…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Exploring the promising application of Be12O12 nanocage for the abatement of paracetamol using DFT simulations by Gul, Sana, Kainat, Ali, Qaisar, Khan, Momin, Ur Rehman, Munir, AlAsmari, Abdullah F., Alasmari, Fawaz, Alharbi, Metab

    Published in Scientific reports (28-10-2023)
    “…The removal of paracetamol from water is of prime concern because of its toxic nature in aquatic environment. In the present research, a detailed DFT study is…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Mathematical modeling for prediction of physicochemical characteristics of cardiovascular drugs via modified reverse degree topological indices by Arockiaraj, Micheal, Greeni, A. Berin, Kalaam, A. R. Abul, Aziz, Tariq, Alharbi, Metab

    “…Global health concerns persist due to the multifaceted nature of heart diseases, which include lifestyle choices, genetic predispositions, and emerging…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Synthesis, molecular structure and urease inhibitory activity of novel bis-Schiff bases of benzyl phenyl ketone: A combined theoretical and experimental approach by Ahmad, Rashid, Khan, Momin, Alam, Aftab, Elhenawy, Ahmed A., Qadeer, Abdul, AlAsmari, Abdullah F., Alharbi, Metab, Alasmari, Fawaz, Ahmad, Manzoor

    Published in Saudi pharmaceutical journal (01-08-2023)
    “…Synthesized bis-Schiff base derivatives as potent urease inhibitor their molecular docking, HOMO, LUMO to indicate the charge transfer from molecule to…”
    Get full text
    Journal Article
  12. 12

    Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities by Javaid, Sana, Farooq, Talha, Rehman, Zohabia, Afzal, Ammara, Ashraf, Waseem, Rasool, Muhammad Fawad, Alqahtani, Faleh, Alsanea, Sary, Alasmari, Fawaz, Alanazi, Mohammed Mufadhe, Alharbi, Metab, Imran, Imran

    “…The incidences of traumatic brain injuries (TBIs) are increasing globally because of expanding population and increased dependencies on motorized vehicles and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmacological evaluation and phytochemical profiling of butanol extract of L. edodes with in- silico virtual screening by Ejaz, Umer, Afzal, Muhammad, Naveed, Muhammad, Amin, Zeemal Seemab, Atta, Asia, Aziz, Tariq, Kainat, Gul, Mehmood, Noshaba, Alharbi, Metab, Alasmari, Abdullah F.

    Published in Scientific reports (08-03-2024)
    “…L. edodes ( L. edodes ) is the most consumed mushroom in the world and has been well known for its therapeutic potential as an edible and medicinal candidate,…”
    Get full text
    Journal Article
  15. 15

    The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3 by Naveed, Muhammad, Ali, Nouman, Aziz, Tariq, Hanif, Nimra, Fatima, Mahnoor, Ali, Imran, Alharbi, Metab, Alasmari, Abdullah F., Albekairi, Thamer H.

    Published in Scientific reports (17-01-2024)
    “…There is no FDA-approved drug for neurological disorders like spinocerebellar ataxia type 3. CAG repeats mutation in the ATXN3 gene, causing spinocerebellar…”
    Get full text
    Journal Article
  16. 16

    Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy by Shahab, Muhammad, Al-Madhagi, Haitham, Zheng, Guojun, Zeb, Amir, Alasmari, Abdullah Fayez, Alharbi, Metab, Alasmari, Fawaz, Khan, Muhammad Qayash, Khan, Momin, Wadood, Abdul

    Published in Scientific reports (02-09-2023)
    “…Cancer immunotherapy has significantly contributed to the treatment of various types of cancers mainly by targeting immune checkpoint inhibitors (ICI). Among…”
    Get full text
    Journal Article
  17. 17

    Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota by Ahmad, Waqar, Din, Ahmad Ud, Khan, Taj Malook, Rehman, Mujeeb Ur, Hassan, Adil, Aziz, Tariq, Alharbi, Metab, Wu, Jianbo

    Published in Frontiers in microbiology (27-03-2024)
    “…The gut microbiota plays an important role in the disease progression of inflammatory bowel disease. Although probiotics are effective against IBD, not many…”
    Get full text
    Journal Article
  18. 18

    Development and immunological evaluation of an mRNA-based vaccine targeting Naegleria fowleri for the treatment of primary amoebic meningoencephalitis by Naveed, Muhammad, Ali, Urooj, Aziz, Tariq, Jabeen, Khizra, Arif, Muhammad Hammad, Alharbi, Metab, Alasmari, Abdullah F., Albekairi, Thamer H.

    Published in Scientific reports (08-01-2024)
    “…More than 95% of patients fall victim to primary amoebic meningoencephalitis (PAM), a fatal disease attacking the central nervous system. Naegleria fowleri , a…”
    Get full text
    Journal Article
  19. 19
  20. 20